Over the past two decades nations of lower-middle income and upper-middle-class consumers have developed. This 'Emerging Middle Class', with an average per capita income of between $1,000 and $12,000, now... Read more
Ten years on, Facebook remains an important channel through which pharma can engage with patients. What has been learned in that time and how have communication strategies evolved within the... Read more
Andrew McConaghie reports on contrasting views on 2014's merger and acquisition rollercoaster ride, and the forces propelling it.
The annual pharma / biotech sector conference hosted by the Financial Times usually yields... Read more
AstraZeneca's (AZ) Duaklir Genuair (aclidinium bromide/formoterol fumarate 340/12 mcg) has been granted Marketing Authorisation (MA) by the European Commission (EC) for use as a maintenance bronchodilator treatment to relieve symptoms... Read more
Novartis' Cosentyx (secukinumab) is the first IL-17A inhibitor to receive a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) as a first-line... Read more
While every pharma company recognises the potential of multichannel marketing to optimize its engagement with prescribers, many are yet to implement it to maximum potential. IMS Health explains how a... View info